A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab
Crossref DOI link: https://doi.org/10.1007/s12325-022-02042-3
Published Online: 2022-01-24
Published Print: 2022-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Villaescusa, Lucinda http://orcid.org/0000-0001-7187-5515
Zaragozá, Francisco
Gayo-Abeleira, Irene
Zaragozá, Cristina
Text and Data Mining valid from 2022-01-24
Version of Record valid from 2022-01-24
Article History
Received: 10 November 2021
Accepted: 6 January 2022
First Online: 24 January 2022